Coronary artery disease (CAD) is the leading cause of death in the United States. Although effective preventive treatments ...

The framework proposed by the authors integrates uncertainty-aware mechanisms at multiple stages of the LLM lifecycle. It ...

The Centers for Medicare & Medicaid Services is seeking inpatient psychiatric facilities to voluntarily participate in a beta test this summer through fall for its IPF patient assessment instrument, a ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

An AI tool that analyzes nurses’ notes for subtle clinical changes helped reduce patient risk of death by 35.6%, length of stay by 11.2% and sepsis risk by 7.5%, according to research published ...

This study aimed to understand challenges in risk communication and informed consent in antimicrobial clinical trials. Design Scoping review. Data sources Searches were conducted in Embase, Medline, ...

The automation allows data to be gathered with minimal errors, enabling researchers to dedicate extra time to progressing clinical ... Archer tool for automation of electronic health record ...

Individuals of African ancestry are at highest risk. Lilly has already moved lepodisiran into late-stage clinical trials. While the drug reduced a cardiovascular risk factor, large trials are ...

The ALIGN-AR trial contributes to the literature by demonstrating high technical success, a reassuring safety profile, and favorable clinical outcomes in high-risk patients with aortic regurgitation ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults with type ... These new data from a phase 3 trial were featured during a late ...

The first clinical trial of a therapy bot that uses generative AI suggests it was as effective as human therapy for participants with depression, anxiety, or risk for developing eating disorders.